A recent study indicated that PFKFB3 overexpression could increase immune evasion and tumorigenesis in hepatocellular carcinoma by NF-κB activation and enhance PDL1 expression [16] and could regulate the NF-κB pathways in ovarian cancer [17]. This evidence concerns the gene PFKFB3 and ovarian carcinoma.